Keep vial sealed until reconstitution
The REDEFINE trials showed that at 68 weeks, participants on the mix had lost an average of 25% of body weight with many still showing downward weight trajectories, suggesting further weight loss might be possible with continued treatment
Not all insurance plans cover tirzepatide for this indication, as the FDA approvals are specifically for diabetes and weight management
Semaglutide has extensive clinical history through its branded injectable and oral forms, with substantial research documenting its mechanisms, efficacy, and safety profile for both Type 2 diabetes management and weight loss support
By leveraging trained and certified coders, you gain access to: Accurate and up-to-date coding for injections and all other services Compliance with CMS and private payor guidelines Real-time denial management and claims tracking Custom reporting and analytics to monitor CPT code usage Support for multiple specialties, from primary care to urgent care and pain management Reimbursement Considerations The average Medicare reimbursement for CPT 96372 (2025 rates may vary by locality) is approximately $15$25, depending on the providers fee schedule
Stay aware of how Semaglutide might affect the absorption of oral medications
